To: Scumbria who wrote (131003 ) 1/30/2001 11:08:43 AM From: Daniel Schuh Read Replies (2) | Respond to of 1571815 Somewhat on that topic: Look at Brazil nytimes.com Patent laws are malleable. Patients are educable. Drug companies are vincible. The world's AIDS crisis is solvable. But not if the drug companies have anything to say about it. This article gets into the rather odd economics by which US companies charge extortionist rates on drugs that were often developed using government money, and then go around strongarming the rest of the world to get them to pay the same extortionist rates. Meanwhile, lots of people are dying. Until a year ago, the triple therapy that has made AIDS a manageable disease in wealthy nations was considered realistic only for those who could afford to pay $10,000 to $15,000 a year or lived in societies that could. The most that poor countries could hope to do was prevent new cases of AIDS through educational programs and condom promotion or to cut mother-to-child transmission and, if they were very lucky, treat some of AIDS's opportunistic infections. But the 32.5 million people with H.I.V. in the developing world had little hope of survival. This was the conventional wisdom. Today, all of these statements are false. . . . Brazil can afford to treat AIDS because it does not pay market prices for antiretroviral drugs -- the most controversial aspect of the country's plan. In 1998, the government began making copies of brand-name drugs, and the price of those medicines has fallen by an average of 79 percent. Brazil now produces some triple therapy for $3,000 a year and expects to do much better, and the price could potentially drop to $700 a year or even less. Brazil is showing that no one who dies of AIDS dies of natural causes. Those who die have been failed -- by feckless leaders who see weapons as more alluring purchases than medicines, by wealthy countries (notably the United States) that have threatened the livelihood of poor nations who seek to manufacture cheap medicine and by the multinational drug companies who have kept the price of antiretroviral drugs needlessly out of reach of the vast majority of the world's population. Er. I'm sure W's chosen AG and the rest of his holy roller team will weigh in on the "right" side on this one. Cheers, Dan.